9,10-Di(naphthalen-2-yl)anthracene

Catalog No. :
ACBAUP036
CAS No. :
122648-99-1
Molecular Formula :
C34H22
Molecular Weight :
430.55

IUPAC Name:9,10-di(naphthalen-2-yl)anthracene

9,10-Di(naphthalen-2-yl)anthracene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$152.00Login to see priceIn stockIn stock
25g97%$608.00Login to see priceInquiryIn stock
100g97%$2047.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name9,10-Di(naphthalen-2-yl)anthracene
IUPAC Name9,10-di(naphthalen-2-yl)anthracene
MDL No.MFCD00028944
Molecular FormulaC34H22
Molecular Weight430.55
SMILESC12=CC=CC=C1C(C3=CC=C4C=CC=CC4=C3)=C5C=CC=CC5=C2C6=CC=C7C=CC=CC7=C6
InChI KeyVIZUPBYFLORCRA-UHFFFAOYSA-N
Synonym9,10-DI(2-NAPHTHYL)ANTHRACENE | 9,10-Di-naphthalen-2-yl-anthracene | 9,10-dinaphthalen-2-ylanthracene | 9,10-Dinaphthalen-2-yl-anthracene | DTXSID10619329 | SB66457 | 9,10-Di(2-naphthyl)anthracene, 99.0% | D4127 | 9,10-Bis(2-naphthyl)anthracene | FT-06553
CAS No.122648-99-1
PubChem CID21881242

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACBAUP036 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUEAM185 route compound structure diagram
    ACUEAM18532316-92-0 In Stock
  4. Then
  5. ACBAUP036 route product structure diagram
    ACBAUP036122648-99-1 In Stock
Inquiry

2. ACBAUP036 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWRYB782 route compound structure diagram
    ACWRYB782474688-73-8 In Stock
  2. Plus
  3. ACUEAM185 route compound structure diagram
    ACUEAM18532316-92-0 In Stock
  4. Then
  5. ACBAUP036 route product structure diagram
    ACBAUP036122648-99-1 In Stock
Inquiry

Comments (0)